Introduced in the Ohio Senate - May 28, 2019
Passed out the Senate Health, Human Services, and Medicaid Committee- November 5, 2019
Passed the Ohio Senate- November 6, 2019
Introduced in the Ohio House- November 12, 2019
The proposed legislation requires doctors prescribing a Mifepristone chemical abortion to also provide written information informing the patient of scientifically proven abortion reversal procedures in the event she changes her mind.
The Mifeprex chemical abortion procedure is a two-day regimen used to terminate early pregnancies by blocking the hormone progesterone needed to sustain pregnancy with the first drug, Mifepristone. A second drug, Misoprostol, stimulates uterine contraction to expel the dead baby. Women who choose chemical abortion and regret it within the first two days of taking the first drug have a chance to save their baby, as long as they have not taken the second drug. The reversal procedure has been proven to be successful in 64-68% of cases. The procedure involves administering progesterone to the mother, which can reverse the impact of the first drug and allow the baby to continue normal development.
Ohio State Senator (R)